EPHA2 and colorectal carcinoma: In general, at least in the early stages of carcinogenesis, CRC typically shows increased expression of EphA2, EphA3, EphA8 and EphB4 (14–18), whereas EphA6, EphA7, and EphB1 show decreased expression (19–21).